| Smiles |
O=C2(OC(C(NC(=O)C(N(C(=O)C1(N(C(=O)C(O)C)CCC1))C)CC(C)C)C(=O)NC(C(O)CC(=O)OC(C(C)C)C(C(C(NC(C(N4(C(C(N(C2CC3(=CC=C(OC)C=C3))C)=O)CCC4))=O)CC(C)C)=O)C)=O)C(C)C)C)
|
| CAS number |
117710-03-9
|
| Polar Surface Area |
287,9
|
| calculated LogS |
-5,208
|
| Molweight |
1098,34
|
| calculated LogP |
2,0668
|
| H-Acceptors |
22
|
| H-Donors |
5
|
| Ro5 violations |
2
|
| Druglikeness |
3,6234
|
| DrugScore |
0,3485761
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,4071
|
| Rat Acute Toxicity |
2,7551
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,0246
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,4823
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA-
|
| Structure |
117710-03-9
|
